Kojima Manabu 小島学

… Alternative Names

KOJIMA MANABU 小島学

Less

Researcher Number	30746970
Affiliation (Current)	2025: 福島県立医科大学, 医学部, 博士研究員
Affiliation (based on the past Project Information) *help	2024: 福島県立医科大学, 医学部, 博士研究員 2021 – 2023: 福島県立医科大学, 医学部, 准教授 2019 – 2020: 福島県立医科大学, 医学部, 博士研究員 2018: 福島県立医科大学, 医学部, 助教 2017: 福島県立医科大学, 医学部, 助手
Review Section/Research Field	Principal Investigator Basic Section 56040:Obstetrics and gynecology-related / Basic Section 49020:Human pathology-related / Tumor biology
Keywords	Principal Investigator バイオマーカー / 細胞間接着分子 / クローディン / シグナル伝達 / 核内受容体 / 子宮内膜癌 / 抗体療法 / プロテオミクス / SPON1 / 卵巣がん … More / がん / 細胞間接着 / がん診断マーカー / クローディン9 / 細胞接着因子 / 子宮体癌 / 癌 / 卵巣癌 / エストロゲンレセプター / エストロゲン / 接着分子 / エストロゲン受容体 Less

Development of novel ovarian cancer theranostics targeting SPON1.Principal Investigator
- Principal Investigator
  
  小島学
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Fukushima Medical University
SPON1を標的とする卵巣がん診断・治療法の開発Principal Investigator
- Principal Investigator
  
  小島学
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56040:Obstetrics and gynecology-related
- Research Institution
  Fukushima Medical University
Biological and clinicopathological significance of CLDN9 expression in endometrial cancerPrincipal Investigator
- Principal Investigator
  
  Kojima Manabu
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 49020:Human pathology-related
- Research Institution
  Fukushima Medical University
The significance of high claudin expression in ovarian cancerPrincipal Investigator
- Principal Investigator
  
  KOJIMA MANABU
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor biology
- Research Institution
  Fukushima Medical University

All 2022 2021 2020 2018 2017

All Journal Article Presentation

[Journal Article] Claudin-9 is a novel prognostic biomarker for endometrial cancer2022
- Author(s)
  Endo Yuta、Sugimoto Kotaro、Kobayashi Makoto、Kobayashi Yasuyuki、Kojima Manabu、Furukawa Shigenori、Soeda Shu、Watanabe Takafumi、Higashi Atsuko、Higashi Tomohito、Hashimoto Yuko、Fujimori Keiya、Chiba Hideki
- Journal Title
  
  International Journal of Oncology
  
  Volume: 61 Issue: 5 Pages: 135-135
- DOI
  10.3892/ijo.2022.5425
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21K06950, KAKENHI-PROJECT-20K16176, KAKENHI-PROJECT-20K18224, KAKENHI-PROJECT-21K15386
[Journal Article] Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α2021
- Author(s)
  Kojima M, Sugimoto K, Kobayashi M, Ichikawa-Tomikawa N, Kashiwagi K, Watanabe T, Soeda S, Fujimori K, Chiba H.
- Journal Title
  
  Mol Cancer Res . in press
  
  Volume: in press
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16176
[Journal Article] Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer2021
- Author(s)
  Rahman Abidur、Kobayashi Makoto、Sugimoto Kotaro、Endo Yuta、Kojima Manabu、Furukawa Shigenori、Watanabe Takafumi、Soeda Shu、Hashimoto Yuko、Fujimori Keiya、Chiba Hideki
- Journal Title
  
  International Journal of Molecular Sciences
  
  Volume: 22 Issue: 7 Pages: 3774-3774
- DOI
  10.3390/ijms22073774
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16176, KAKENHI-PROJECT-21K06950, KAKENHI-PROJECT-20K18224, KAKENHI-PROJECT-21K15386, KAKENHI-PROJECT-19K16615
[Journal Article] Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer2020
- Author(s)
  Kojima Manabu、Sugimoto Kotaro、Tanaka Mizuko、Endo Yuta、Kato Hitomi、Honda Tsuyoshi、Furukawa Shigenori、Nishiyama Hiroshi、Watanabe Takafumi、Soeda Shu、Fujimori Keiya、Chiba Hideki
- Journal Title
  
  Cancers
  
  Volume: 12 Issue: 10 Pages: 2748-2748
- DOI
  10.3390/cancers12102748
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K16176, KAKENHI-PROJECT-20K18224, KAKENHI-PROJECT-19K16615
[Presentation] Claudin-9 is a novel biomarker of the prognosis of Endometrial cancer2022
- Author(s)
  Yuta Endo, Shu Soeda, Tetsu Sato, Chikako Okabe, Makiko Ueda, Norihito Kamo, Manabu Kojima, Shigeori Furukawa, Takafumi Watanabe, Keiya Fujimori
- Organizer
  第74回日本産科婦人科学会学術講演会
- Data Source
  KAKENHI-PROJECT-20K16176
[Presentation] THE HIGH EXPRESSION OF CLAUDIN-6 IS A POOR PROGNOSTIC FACTOR IN UTERINE ENDOMETRIAL CARCINOMA2018
- Author(s)
  MANABU KOJIMA
- Organizer
  17th Biennial Meeting of the International Gynecologic Cancer Society (IGCS 2018)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K17981
[Presentation] Clinicopathological significance of claudin-6 expression in uterine endometrial cancer2017
- Author(s)
  Kojima.M
- Organizer
  第69回日本産科婦人科学会
- Data Source
  KAKENHI-PROJECT-17K17981

1. 小林信 (60761947)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
2. 杉本幸太郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Kojima Manabu 小島 学

KOJIMA MANABU 小島 学

Research Projects

Research Products

Co-Researchers

Development of novel ovarian cancer theranostics targeting SPON1.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

SPON1を標的とする卵巣がん診断・治療法の開発Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Biological and clinicopathological significance of CLDN9 expression in endometrial cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

The significance of high claudin expression in ovarian cancerPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Claudin-9 is a novel prognostic biomarker for endometrial cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Aberrant Claudin-6-Adhesion Signaling Promotes Endometrial Cancer Progression via Estrogen Receptor α2021

Author(s)

Journal Title

Data Source

[Journal Article] Reduced Claudin-12 Expression Predicts Poor Prognosis in Cervical Cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer2020

Author(s)

Journal Title

DOI

Data Source

[Presentation] Claudin-9 is a novel biomarker of the prognosis of Endometrial cancer2022

Author(s)

Organizer

Data Source

[Presentation] THE HIGH EXPRESSION OF CLAUDIN-6 IS A POOR PROGNOSTIC FACTOR IN UTERINE ENDOMETRIAL CARCINOMA2018

Author(s)

Organizer

Data Source

[Presentation] Clinicopathological significance of claudin-6 expression in uterine endometrial cancer2017

Author(s)

Organizer

Data Source

Kojima Manabu 小島学

KOJIMA MANABU 小島学